Endo et al. (2022) demonstrated that many known AD risk genes (e.g., Apoe, Clu, and Fermt2) are enriched in cortical and hippocampal astrocytes, brain areas primarily affected in AD. This evidence concerns the gene CLU and Alzheimer disease.